Stock data
OptimizeRx Corporation (OPRX)
OptimizeRx Corporation (OPRX) reported revenue of US$109.43M and net income of US$5.13M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$109.43M | US$73.59M | US$11.69M | US$5.13M | — |
| 2024 | US$92.13M | US$59.38M | -US$13.71M | -US$20.11M | — |
| 2023 | US$71.52M | US$42.90M | -US$26.40M | -US$17.57M | — |
| 2022 | US$1.02M | US$38.97M | -US$12.29M | -US$11.44M | — |
| 2021 | US$4.52M | US$35.64M | US$0.36M | US$0.38M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$20.50M | -US$0.70M | — |
| 2026-03-31 | US$19.84M | -US$0.49M | — |
| 2025-12-31 | US$32.24M | US$5.02M | — |
| 2025-09-30 | US$26.07M | US$0.78M | — |
| 2025-06-30 | US$29.20M | US$1.53M | — |
| 2025-03-31 | US$21.93M | -US$2.20M | — |
| 2024-12-31 | US$32.32M | -US$0.08M | — |
| 2024-09-30 | US$21.31M | -US$9.12M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.